Search

Search

このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

ホーム
...
研究分野医療科学流行病学について流行病学的モデリング
LEVOECMO ランダム化臨床試験

LEVOECMO ランダム化臨床試験

Alain Combes ^1,2, Ouriel Saura ^1,2, Nicolas Nesseler ³, Said Lebbah ⁴, Bertrand Rozec ^5,6, Bruno Levy ^7,8,9, Jean-Luc Fellahi ^10,11, Antoine Beurton ^12,13, Simon Meslin ¹⁴, Philippe Gaudard ¹⁵, Adrien Bouglé ^16,17, André Vincentelli ¹⁸, Romain Sonneville ^19,20, Guillaume Lebreton ^1,21, David Lévy ^1,2, Alexandre Ouattara ^12,13, Florence Tubach ^4,22,

Alain Combes ^1,2, Ouriel Saura ^1,2, Nicolas Nesseler ³

¹INSERM, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition, Sorbonne Université, Paris, France.
²AP-HP, Service de Médecine Intensive-Réanimation, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France.
³INSERM, CIC 1414 (Centre d'Investigation Clinique de Rennes), INRAE, INSERM, Institut NUMECAN-UMR_A 1341, UMR_S 1241, Department of Anesthesia, Critical Care and Perioperative Medicine, Pontchaillou, University Hospital of Rennes, University of Rennes, CHU Rennes, Rennes, France.
⁴AP-HP, Unité de Recherche Clinique PSL-CFX, Hôpital Pitié Salpêtrière, Paris, France.
⁵Service d'Anesthésie-Réanimation, Nantes Université, CHU Nantes, Hôpital Laënnec, Nantes, France.
⁶Nantes Université, CHU Nantes, CNRS, INSERM, l'Institut du Thorax, Nantes, France.
⁷Médecine Intensive et Réanimation, CHRU Nancy, Pôle Cardio-Médico-Chirurgical, Vandoeuvre-les-Nancy, France.
⁸Faculté de Médecine, INSERM U1116, Vandoeuvre-les-Nancy, France.
⁹Université de Lorraine, Nancy, France.
¹⁰Service d'Anesthésie-Réanimation, Hôpital Universitaire Louis Pradel, Hospices Civils de Lyon, Lyon, France.
¹¹Laboratoire Carmen, INSERM UMR 1060, Université Claude Bernard Lyon 1, Lyon, France.
¹²Department of Cardiovascular Anesthesia and Critical Care, CHU Bordeaux, Bordeaux, France.
¹³Biologie des Maladies Cardiovasculaires, U1034, Université de Bordeaux, INSERM, Pessac, France.
¹⁴AP-HP, Service d'Anesthésie-Réanimation et Médecine Peri-Opératoire, Hôpital Européen Georges Pompidou, Paris, France.
¹⁵Department of Anesthesiology and Critical Care Medicine Arnaud de Villeneuve, Montpellier University Hospital, University of Montpellier, and PhyMedExp, INSERM, CNRS, Montpellier, France.
¹⁶GRC 29, Groupe de Recherche Clinique en Anesthésie Réanimation Médecine Périopératoire, ARPE, Sorbonne Université, Paris, France.
¹⁷APHP, DMU DREAM, Department of Anesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Paris, France.
¹⁸Department of Cardiac Surgery, University of Lille, CHU Lille, Lille, France.
¹⁹Université Paris Cité, IAME, INSERM UMR1137, Paris, France.
²⁰AP-HP, Médecine Intensive Réanimation, Hôpital Bichat-Claude Bernard, Paris, France.
²¹APHP, Thoracic and Cardiovascular Department, Pitié-Salpêtrière Hospital, Paris, France.
²²Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe PEPITES, AP-HP, Hôpital Pitié Salpêtrière, Département de Santé Publique, Paris, France.

⁰INSERM, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition, Sorbonne Université, Paris, France.

Jama +

|

2025年12月1日

関連する実験動画

These videos have been matched automatically. Contact us if they are not relevant.

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

See all related videos

まとめ

No abstract available on PubMed

関連する実験動画

自動的に一致したビデオです Contact us もしそれらが関連していない場合

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

See all related videos

関連する概念動画

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Cardiopulmonary Resuscitation IV: Pharmacological Management

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Heart Failure III: Clinical Manifestations

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies